Multi-Scale Agent-Based Multiple Myeloma Cancer Modeling and the Related Study of the Balance between Osteoclasts and Osteoblasts.

<h4>Research background</h4>Currently, multiple myeloma is the second most common hematological malignancy in the U.S., constituting 1% of all cancers. With conventional treatment, the median survival time is typically 3-4 years, although it can be extended to 5-7 years or longer with ad...

Full description

Saved in:
Bibliographic Details
Main Authors: Minna Qiao, Dan Wu, Michelle Carey, Xiaobo Zhou, Le Zhang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0143206&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!